These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6872291)

  • 1. Propranolol in pregnancy three year prospective study.
    Livingstone I; Craswell PW; Bevan EB; Smith MT; Eadie MJ
    Clin Exp Hypertens B; 1983; 2(2):341-50. PubMed ID: 6872291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic propranolol administration during pregnancy. Maternal pharmacokinetics.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 25(4):481-90. PubMed ID: 6653642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma.
    Smith MT; Livingstone I; Hooper WD; Eadie MJ; Triggs EJ
    Ther Drug Monit; 1983; 5(1):87-93. PubMed ID: 6845404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hypertensive therapy with propranolol during pregnancy and lactation.
    Taylor EA; Turner P
    Postgrad Med J; 1981 Jul; 57(669):427-30. PubMed ID: 7312737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of pregnancy on drug action: concentration-effect modelling with propranolol.
    Rubin PC; Butters L; McCabe R; Kelman A
    Clin Sci (Lond); 1987 Jul; 73(1):47-52. PubMed ID: 3608376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of acebutolol with methyldopa in hypertensive pregnancy.
    Williams ER; Morrissey JR
    Pharmatherapeutica; 1983; 3(7):487-91. PubMed ID: 6669592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report.
    Bott-Kanner G; Schweitzer A; Schoenfeld A; Joel-Cohen J; Rosenfeld JB
    Isr J Med Sci; 1978 Apr; 14(4):466-8. PubMed ID: 669924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of propranolol in the human maternal-placental-foetal unit.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 24(6):727-32. PubMed ID: 6884410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy].
    Peiker G; Siegert C; Glöckner R; Völkner E; Traeger A
    Pharmazie; 1985 Sep; 40(9):645-7. PubMed ID: 4070348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
    Pritchard F; Schneck D; Hayes A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1978 Jun; 67(6):826-31. PubMed ID: 660467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension.
    Oumachigui A; Verghese M; Balachander J
    Indian Heart J; 1992; 44(1):39-41. PubMed ID: 1398694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of alphamethyldopa during the pregnancy-puerperium cycle in hypertensive patients and evaluation of their offspring up to their 3rd year of life].
    De Andrade J
    Arq Bras Cardiol; 1990 Aug; 55(2):137-9. PubMed ID: 2073176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol for the treatment of hypertension in pregnancy.
    Eliahou HE; Silverberg DS; Reisin E; Romem I; Mashiach S; Serr DM
    Br J Obstet Gynaecol; 1978 Jun; 85(6):431-6. PubMed ID: 656347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants.
    White WB; Andreoli JW; Cohn RD
    Clin Pharmacol Ther; 1985 Apr; 37(4):387-90. PubMed ID: 3838502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy.
    Horvath JS; Phippard A; Korda A; Henderson-Smart DJ; Child A; Tiller DJ
    Obstet Gynecol; 1985 Nov; 66(5):634-8. PubMed ID: 3903581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.
    Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy.
    Thorley KJ; McAinsh J
    Biopharm Drug Dispos; 1983; 4(3):299-301. PubMed ID: 6626704
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension.
    Montan S; Anandakumar C; Arulkumaran S; Ingemarsson I; Ratnam SS
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):152-6. PubMed ID: 8420318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.